The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune signatures to affect overall survival (OS) and response to bevacizumab (Bev) or cetuximab (Cet) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance).
 
Federico Innocenti
Consulting or Advisory Role - Emerald Lake Safety; Symberix
Patents, Royalties, Other Intellectual Property - United States Patent: "Flavopiridol drug combinations and methods with reduced side effects", Ratain MJ, Innocenti F, Iyer L. Filed on April 12, 2001, serial number 09/835,082.; United States Patent: “Optimization of cancer treatment with irinotecan”, Ratain MJ, Innocenti F, Karabatsos P, Grimsley C, Di Rienzo A. Filed on February 12, 2003, serial number 60/446,942.; United States Provisional Application ”Methods of identifying risk of bevacizumab-induced proteinuria and hypertension”, Innocenti F, Quintanilha J, Lin D, Owzar K, Wang J. Filed on September 20, 2019, serial number 62/903,442.
 
Akram Yazdani
No Relationships to Disclose
 
Xueping Qu
Employment - BeiGene (I); Genentech
Stock and Other Ownership Interests - BeiGene (I); Genentech/Roche
 
Fang-Shu Ou
No Relationships to Disclose
 
Scott Van Buren
No Relationships to Disclose
 
Omar Kabbarah
Employment - ORIC Pharmaceuticals; Zai Lab
Stock and Other Ownership Interests - ORIC Pharmaceuticals; Zai Lab
Research Funding - ORIC Pharmaceuticals; Zai Lab
Travel, Accommodations, Expenses - ORIC Pharmaceuticals; Zai Lab
 
Charles David Blanke
No Relationships to Disclose
 
Alan P. Venook
Consulting or Advisory Role - Array BioPharma; Merck Sharp & Dohme
Research Funding - Amgen; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Genentech; Roche
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; GlaxoSmithKline; Isofol Medical; Merck Serono; Roche
Consulting or Advisory Role - Bayer; BMS; GlaxoSmithKline; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono
 
Benjamin Garrett Vincent
Stock and Other Ownership Interests - GeneCentric